Entering text into the input field will update the search result below

Teva wins U.K. approval for Lucentis biosimilar

Teva Canada Ltd facility in Whitchurch-Stouffville, On, Canada.

JHVEPhoto/iStock Editorial via Getty Images

  • Teva Pharmaceutical (NYSE:TEVA) announced on Tuesday that the U.K. Medicines & Healthcare Regulatory Agency (MHRA) licensed Ongavia, a biosimilar to wet AMD medication Lucentis marketed by the Genentech unit of Roche (

Recommended For You

About TEVA Stock

SymbolLast Price% Chg
Market Cap
PE
Yield (TTM)
Rev Growth (YoY)
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
TEVA--
Teva Pharmaceutical Industries Limited